WGU C785 Biochemistry Comprehensive Final Exam Prep
Document | 2026/2027 Edition | 250 Verified Questions
WGU C785 Biochemistry Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for students enrolled in
WGU C785 Biochemistry. It contains 250 verified questions that closely simulate the Western
Governors University Objective Assessment (OA), providing a robust tool for final exam readiness.
Each question is accompanied by a detailed rationale explaining the correct answer, as well as analysis
of incorrect options to deepen understanding. The content is organized by major biochemical themes,
ensuring a thorough review of all critical concepts. This resource is updated for the 2026/2027
academic year and reflects the most current curriculum guidelines.
Key Features:
Protein structure and function, including amino acid properties and enzyme kinetics
Metabolic pathways: glycolysis, gluconeogenesis, citric acid cycle, and oxidative phosphorylation
Lipid metabolism and membrane dynamics
Nucleic acid biochemistry and molecular biology (DNA replication, transcription, translation)
Regulation of gene expression and signal transduction
Clinical applications and integrated case studies
Updates for 2026:
- Aligned with the latest WGU C785 course objectives and assessment blueprint for 2026/2027
- Incorporated recent advances in biochemical research and clinical relevance
- Enhanced rationales to clarify common misconceptions and reinforce key concepts
- Added new questions on emerging topics such as CRISPR and metabolic regulation
- Revised answer explanations to ensure alignment with current WGU grading standards
Abstract:
This examination preparation compendium is an essential resource for students undertaking the WGU C785
Biochemistry final assessment. The document comprises 250 meticulously curated questions that mirror the format
and difficulty of the official Objective Assessment. Each question is paired with a comprehensive rationale that not
only justifies the correct answer but also dissects each distractor, fostering a deeper conceptual grasp. The
material is systematically organized into thematic modules, covering the entirety of the biochemistry curriculum,
from molecular structure to complex metabolic integration. Emphasis is placed on the application of biochemical
principles to clinical scenarios, thereby enhancing critical thinking and problem-solving skills. This edition has
been rigorously updated to reflect the 2026/2027 academic year, ensuring alignment with the most recent course
guidelines and learning outcomes. By engaging with this resource, students can confidently identify knowledge
gaps, reinforce mastery, and approach the final exam with assurance. The detailed rationales serve as a
self-teaching tool, making this document invaluable for both initial learning and final review.
Keywords:
WGU C785, Biochemistry final exam, Objective Assessment, Verified questions, Detailed rationales, Metabolic
pathways, Protein structure, Molecular biology
Answer Format:
Each question is presented in multiple-choice format, followed by the correct answer and a comprehensive
rationale. The rationale explains why the correct answer is right and why each incorrect option is wrong, often
including biochemical context and clinical relevance. This format facilitates active learning and ensures a deep
understanding of the underlying concepts.
Page 1
,Compliance Checklist:
Aligned with WGU C785 course competencies and objectives
Updated for 2026/2027 academic year
Includes 250 verified questions with detailed rationales
Simulates the format and rigor of the WGU Objective Assessment
Answers are graded A+ and reflect current standards
Suitable for self-assessment and comprehensive review
Content Area Overview:
Content Area Questions Key Topics Weight
Amino Acids and Protein 1-40 Amino acid classification, peptide bonds, 16%
Structure secondary structure, tertiary structure,
protein folding
Enzyme Kinetics and Regulation 41-70 Michaelis-Menten kinetics, inhibitors, 12%
allosteric regulation, enzyme mechanisms
Carbohydrate Metabolism 71-100 Glycolysis, gluconeogenesis, pentose 12%
phosphate pathway, glycogen metabolism
Lipid Metabolism 101-130 Fatty acid oxidation, fatty acid synthesis, 12%
ketone bodies, cholesterol metabolism
Nucleic Acid Biochemistry and 131-170 DNA structure, replication, transcription, 16%
Molecular Biology translation, mutations, DNA repair
Gene Expression and Regulation 171-200 Operons, transcription factors, epigenetics, 12%
RNA interference, signal transduction
Metabolic Integration and 201-250 Hormonal regulation, metabolic disorders, 20%
Clinical Applications nutrition, case studies
Page 2
,Q1. In a patient with a mitochondrial enzyme defect that impairs the conversion of
pyruvate to acetyl-CoA, which of the following metabolic outcomes is most likely?
A. Increased rate of fatty acid synthesis in the liver
B. Elevated ratio of lactate to pyruvate in the blood
C. Enhanced gluconeogenesis from alanine
D. Increased activity of the citric acid cycle
Correct Answer: B. Elevated ratio of lactate to pyruvate in the blood
Rationale: The defect in pyruvate dehydrogenase (PDH) prevents pyruvate from entering
the TCA cycle, forcing pyruvate to be reduced to lactate to regenerate NAD+. This results
in an elevated lactate/pyruvate ratio. Fatty acid synthesis would be decreased,
gluconeogenesis from alanine would be impaired (since alanine transamination to
pyruvate would not help), and TCA cycle activity would be diminished.
Why Wrong:
A - Fatty acid synthesis requires acetyl-CoA from pyruvate, which is deficient here.
C - Gluconeogenesis from alanine requires pyruvate carboxylase, but the block in
PDH does not directly impair that pathway; however, the carbon from alanine could
still be used, but the lactate/pyruvate ratio is more directly affected.
D - The TCA cycle would be starved of acetyl-CoA, so its activity would decrease.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 16
Q2. In a binding assay, a protein binds ligand X with a Kd of 1 µM. Which of the
following modifications would most likely increase the fraction of ligand bound at a
free ligand concentration of 0.5 µM?
A. Increase the total protein concentration
B. Decrease the total protein concentration
C. Add a competitive inhibitor
D. Increase the temperature to 37°C
Correct Answer: A. Increase the total protein concentration
Rationale: The fraction of ligand bound depends on the concentration of free protein and
the Kd. Increasing total protein concentration increases the number of binding sites, thus
increasing the fraction of ligand bound at a given free ligand concentration. Decreasing
protein would have the opposite effect. A competitive inhibitor would reduce binding.
Temperature may affect Kd, but not predictably in the desired direction.
Why Wrong:
B - Lower protein concentration reduces available binding sites, decreasing bound
fraction.
C - Competitive inhibitor competes for the binding site, reducing the bound fraction.
D - Temperature effects are unpredictable and not necessarily increasing binding; Kd
may change but not guaranteed.
Page 3
, Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 5
Q3. For an enzyme that follows Michaelis-Menten kinetics, which of the following
statements about the effect of a noncompetitive inhibitor is true?
A. It increases Km and decreases Vmax
B. It decreases Km and leaves Vmax unchanged
C. It leaves Km unchanged and decreases Vmax
D. It increases both Km and Vmax
Correct Answer: C. It leaves Km unchanged and decreases Vmax
Rationale: Noncompetitive inhibitors bind to an allosteric site and reduce the number of
functional enzyme molecules, thus decreasing Vmax. Km is unchanged because the affinity
of the enzyme for substrate is not altered. Competitive inhibitors increase Km, while
uncompetitive inhibitors decrease both Km and Vmax.
Why Wrong:
A - This is characteristic of a competitive inhibitor, not noncompetitive.
B - This pattern is not typical of any common reversible inhibitor.
D - Inhibitors do not increase Vmax; they only decrease or leave it unchanged.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 6
Q4. In the Cori cycle, which of the following conversions occurs in the liver?
A. Glucose to pyruvate
B. Lactate to glucose
C. Pyruvate to lactate
D. Glucose to lactate
Correct Answer: B. Lactate to glucose
Rationale: The Cori cycle involves lactate produced in muscle being transported to the
liver, where it is converted back to glucose via gluconeogenesis. Muscle performs
glycolysis converting glucose to lactate, while the liver performs gluconeogenesis
converting lactate to glucose.
Why Wrong:
A - This occurs in muscle, not liver, in the Cori cycle.
C - This occurs in muscle during anaerobic glycolysis.
D - This is the overall process in muscle, not liver.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 16
Q5. Which of the following is the direct allosteric activator of pyruvate carboxylase?
A. ATP
B. Acetyl-CoA
C. ADP
Page 4
Document | 2026/2027 Edition | 250 Verified Questions
WGU C785 Biochemistry Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for students enrolled in
WGU C785 Biochemistry. It contains 250 verified questions that closely simulate the Western
Governors University Objective Assessment (OA), providing a robust tool for final exam readiness.
Each question is accompanied by a detailed rationale explaining the correct answer, as well as analysis
of incorrect options to deepen understanding. The content is organized by major biochemical themes,
ensuring a thorough review of all critical concepts. This resource is updated for the 2026/2027
academic year and reflects the most current curriculum guidelines.
Key Features:
Protein structure and function, including amino acid properties and enzyme kinetics
Metabolic pathways: glycolysis, gluconeogenesis, citric acid cycle, and oxidative phosphorylation
Lipid metabolism and membrane dynamics
Nucleic acid biochemistry and molecular biology (DNA replication, transcription, translation)
Regulation of gene expression and signal transduction
Clinical applications and integrated case studies
Updates for 2026:
- Aligned with the latest WGU C785 course objectives and assessment blueprint for 2026/2027
- Incorporated recent advances in biochemical research and clinical relevance
- Enhanced rationales to clarify common misconceptions and reinforce key concepts
- Added new questions on emerging topics such as CRISPR and metabolic regulation
- Revised answer explanations to ensure alignment with current WGU grading standards
Abstract:
This examination preparation compendium is an essential resource for students undertaking the WGU C785
Biochemistry final assessment. The document comprises 250 meticulously curated questions that mirror the format
and difficulty of the official Objective Assessment. Each question is paired with a comprehensive rationale that not
only justifies the correct answer but also dissects each distractor, fostering a deeper conceptual grasp. The
material is systematically organized into thematic modules, covering the entirety of the biochemistry curriculum,
from molecular structure to complex metabolic integration. Emphasis is placed on the application of biochemical
principles to clinical scenarios, thereby enhancing critical thinking and problem-solving skills. This edition has
been rigorously updated to reflect the 2026/2027 academic year, ensuring alignment with the most recent course
guidelines and learning outcomes. By engaging with this resource, students can confidently identify knowledge
gaps, reinforce mastery, and approach the final exam with assurance. The detailed rationales serve as a
self-teaching tool, making this document invaluable for both initial learning and final review.
Keywords:
WGU C785, Biochemistry final exam, Objective Assessment, Verified questions, Detailed rationales, Metabolic
pathways, Protein structure, Molecular biology
Answer Format:
Each question is presented in multiple-choice format, followed by the correct answer and a comprehensive
rationale. The rationale explains why the correct answer is right and why each incorrect option is wrong, often
including biochemical context and clinical relevance. This format facilitates active learning and ensures a deep
understanding of the underlying concepts.
Page 1
,Compliance Checklist:
Aligned with WGU C785 course competencies and objectives
Updated for 2026/2027 academic year
Includes 250 verified questions with detailed rationales
Simulates the format and rigor of the WGU Objective Assessment
Answers are graded A+ and reflect current standards
Suitable for self-assessment and comprehensive review
Content Area Overview:
Content Area Questions Key Topics Weight
Amino Acids and Protein 1-40 Amino acid classification, peptide bonds, 16%
Structure secondary structure, tertiary structure,
protein folding
Enzyme Kinetics and Regulation 41-70 Michaelis-Menten kinetics, inhibitors, 12%
allosteric regulation, enzyme mechanisms
Carbohydrate Metabolism 71-100 Glycolysis, gluconeogenesis, pentose 12%
phosphate pathway, glycogen metabolism
Lipid Metabolism 101-130 Fatty acid oxidation, fatty acid synthesis, 12%
ketone bodies, cholesterol metabolism
Nucleic Acid Biochemistry and 131-170 DNA structure, replication, transcription, 16%
Molecular Biology translation, mutations, DNA repair
Gene Expression and Regulation 171-200 Operons, transcription factors, epigenetics, 12%
RNA interference, signal transduction
Metabolic Integration and 201-250 Hormonal regulation, metabolic disorders, 20%
Clinical Applications nutrition, case studies
Page 2
,Q1. In a patient with a mitochondrial enzyme defect that impairs the conversion of
pyruvate to acetyl-CoA, which of the following metabolic outcomes is most likely?
A. Increased rate of fatty acid synthesis in the liver
B. Elevated ratio of lactate to pyruvate in the blood
C. Enhanced gluconeogenesis from alanine
D. Increased activity of the citric acid cycle
Correct Answer: B. Elevated ratio of lactate to pyruvate in the blood
Rationale: The defect in pyruvate dehydrogenase (PDH) prevents pyruvate from entering
the TCA cycle, forcing pyruvate to be reduced to lactate to regenerate NAD+. This results
in an elevated lactate/pyruvate ratio. Fatty acid synthesis would be decreased,
gluconeogenesis from alanine would be impaired (since alanine transamination to
pyruvate would not help), and TCA cycle activity would be diminished.
Why Wrong:
A - Fatty acid synthesis requires acetyl-CoA from pyruvate, which is deficient here.
C - Gluconeogenesis from alanine requires pyruvate carboxylase, but the block in
PDH does not directly impair that pathway; however, the carbon from alanine could
still be used, but the lactate/pyruvate ratio is more directly affected.
D - The TCA cycle would be starved of acetyl-CoA, so its activity would decrease.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 16
Q2. In a binding assay, a protein binds ligand X with a Kd of 1 µM. Which of the
following modifications would most likely increase the fraction of ligand bound at a
free ligand concentration of 0.5 µM?
A. Increase the total protein concentration
B. Decrease the total protein concentration
C. Add a competitive inhibitor
D. Increase the temperature to 37°C
Correct Answer: A. Increase the total protein concentration
Rationale: The fraction of ligand bound depends on the concentration of free protein and
the Kd. Increasing total protein concentration increases the number of binding sites, thus
increasing the fraction of ligand bound at a given free ligand concentration. Decreasing
protein would have the opposite effect. A competitive inhibitor would reduce binding.
Temperature may affect Kd, but not predictably in the desired direction.
Why Wrong:
B - Lower protein concentration reduces available binding sites, decreasing bound
fraction.
C - Competitive inhibitor competes for the binding site, reducing the bound fraction.
D - Temperature effects are unpredictable and not necessarily increasing binding; Kd
may change but not guaranteed.
Page 3
, Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 5
Q3. For an enzyme that follows Michaelis-Menten kinetics, which of the following
statements about the effect of a noncompetitive inhibitor is true?
A. It increases Km and decreases Vmax
B. It decreases Km and leaves Vmax unchanged
C. It leaves Km unchanged and decreases Vmax
D. It increases both Km and Vmax
Correct Answer: C. It leaves Km unchanged and decreases Vmax
Rationale: Noncompetitive inhibitors bind to an allosteric site and reduce the number of
functional enzyme molecules, thus decreasing Vmax. Km is unchanged because the affinity
of the enzyme for substrate is not altered. Competitive inhibitors increase Km, while
uncompetitive inhibitors decrease both Km and Vmax.
Why Wrong:
A - This is characteristic of a competitive inhibitor, not noncompetitive.
B - This pattern is not typical of any common reversible inhibitor.
D - Inhibitors do not increase Vmax; they only decrease or leave it unchanged.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 6
Q4. In the Cori cycle, which of the following conversions occurs in the liver?
A. Glucose to pyruvate
B. Lactate to glucose
C. Pyruvate to lactate
D. Glucose to lactate
Correct Answer: B. Lactate to glucose
Rationale: The Cori cycle involves lactate produced in muscle being transported to the
liver, where it is converted back to glucose via gluconeogenesis. Muscle performs
glycolysis converting glucose to lactate, while the liver performs gluconeogenesis
converting lactate to glucose.
Why Wrong:
A - This occurs in muscle, not liver, in the Cori cycle.
C - This occurs in muscle during anaerobic glycolysis.
D - This is the overall process in muscle, not liver.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 16
Q5. Which of the following is the direct allosteric activator of pyruvate carboxylase?
A. ATP
B. Acetyl-CoA
C. ADP
Page 4
